Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Otsuka

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Otsuka's 2012 sales performance.

Otsuka

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance It was formed through the collaboration of leading pharma companies - Biogen, Eli Lilly and Company, GSK, Johnson &Johnson, Otsuka (Astex), Pfizer and Takeda -, the UK Department of Health and Social Care

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment

Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment Another orphan drug, Novelion’s Myalepta (metreleptin) also received a positive opinion, for the treatment of leptin deficiency, while Lundbeck and Otsuka’s Rxulti (brexpiprazole) was recommended for the treatment of

Otsuka utilises Envision Pharma Group’s medical affairs platform

Otsuka utilises Envision Pharma Group’s medical affairs platform The programme offers Otsuka’s stakeholders a more “user friendly” experience. In a bid to step up its medical affairs-related activity, Otsuka has introduced iEnvision - a programme by Envision Pharma ... library. According to Envision Pharma Group,

Otsuka finally gets FDA OK for kidney disease drug

Otsuka finally gets FDA OK for kidney disease drug Approval at last for rare disease treatment. At the second attempt, Otsuka has been given a green light in the US for tolvaptan, the first drug to be FDA-approved for ... Otsuka said recently it expects US approval for PKD to drive sales up to 81bn yen

Otsuka rewards digital health startup NeuroFlow

Otsuka rewards digital health startup NeuroFlow Andrew Wright, vice president of digital medicine for Otsuka, said: “At Otsuka, we are proud of our commitment to developing innovative solutions. ... Christopher Molaro, NeuroFlow CEO and co-founder, said: “The support of Otsuka and Psych Congress

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...